JPMorgan downgraded Healthcare Realty Trust (HR) to Neutral from Overweight with an unchanged price target of $19. The firm made several rating changes in conjunction with its 2025 real estate investment trust and real estate services outlook. The analyst recognizes that Healthcare Realty management’s efforts to drive its multitenant occupancy have been paying off in recent quarters, but says this progress may be overshadowed over the near-term by the company’s CEO search and what actions that person might take to shape its go-forward path.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HR:
- Healthcare Realty Trust price target raised to $17 from $16 at Wells Fargo
- Healthcare Realty Trust announces CFO, general counsel changes
- Healthcare Realty Trust Announces Key Leadership Changes
- Healthcare Realty Trust Revamps Board for Strategic Growth
- Healthcare Realty Trust Announces Leadership Transition